2008 Annual Meeting | Case Studies in Stroke

Date Wednesday 04/16/08

Time 07:00 PM - 10:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Philip B. Gorelick, MD, MPH, FAAN

Topic(s)

Learning Objectives Participants should better understand unusual causes of stroke in relation to diagnosis and treatment, identification of stroke mimics, and controversies in stroke diagnosis or treatment.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
07:00 PM - 07:20 PM		Case Study 1: X Marks the Spot Louis R. Caplan, MD, FAAN
07:00 PM - 10:00 PM		Reception
07:20 PM - 07:40 PM		Case Study 2: White Matter Disease: Now You See It and Now You Do Not Louis R. Caplan, MD, FAAN
07:40 PM - 08:00 PM		Case Study 3: A Call to Stroke Louis R. Caplan, MD, FAAN
08:00 PM - 08:15 PM		Break
08:15 PM - 08:35 PM		Case Study 4: An Uncommon Strokelike Manifestation of a Relatively Common Disease Philip B. Gorelick, MD, MPH, FAAN
08:35 PM - 08:55 PM		Case Study 5: A Challenging Case of White Matter Disease: CADASIL, Vasculitis, Something Else? Philip B. Gorelick, MD, MPH, FAAN
08:55 PM - 09:15 PM		Case Study 6: Controversies Regarding Antiplatelet Therapy in Recurrent Stroke Prevention Philip B. Gorelick, MD, MPH, FAAN
09:15 PM - 09:30 PM		Break
09:30 PM - 10:00 PM		Discussion: Presentation of Challenging Cases by Participants

Faculty Disclosures
Louis R. Caplan, MD, FAAN	No disclosure on file
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.

��ɫ��

��ɫ��